Categories: News

Navigating High Drug Costs: Study Finds Consumers Want Their Physician to Lead

RazorMetrics’ drug cost survey reveals consumers want their physician to take the lead on lowering their prescription costs.

AUSTIN, Texas, April 20, 2022 /PRNewswire/ — RazorMetrics’ recent consumer opinion survey about drug costs found some surprising results. Despite the explosion in consumer-driven savings apps, healthcare consumers want their physician to take the lead. The survey found that 80% of respondents would prefer their physician be the one to choose a lower cost drug for their prescription and do so automatically.

Sticker shock at the pharmacy is a lose-lose situation for everyone. High prescription costs are forcing some patients to skip doses, split pills, or stop treatment altogether. RazorMetrics’ drug cost survey asked, “if a prescription is too expensive what do you do?” 9.3% of survey respondents said they “Forget about it and go home.” Other responses included “Pay for it anyway” (22.3%), “Ask the pharmacist about a discount” (35.3%), “Call my doctor” (21.7%), and “Call my insurance” (11.3%). To patients, physicians, and pharmacists none of these options is a good outcome.

Physicians are trying to control costs; 72% of survey respondents said their physician talks to them about drug prices but, unfortunately, physicians cannot prescribe the lowest cost medication without help. A study published in Jama Network Open, “Accuracy of Physician Estimates of Out-of-Pocket Costs for Medication Filling,” found that when physicians were given drug price and patient insurance data, only 21% could accurately estimate out-of-pocket costs for their patient. The study authors said, “one-third of US residents have trouble paying their medical bills. They often turn to their physicians for help navigating health costs and insurance coverage.” This sets the physician up for failure.

“As a cardiologist with an active practice, I can attest to the frustration doctors feel when we get a call from a patient at the pharmacy. We try another medication hoping that it will be covered by the patient’s health plan. The system is built on a trial by error model,” said Dr. Siva Mohan, MD and co-founder of RazorMetrics. “It’s inefficient and deeply frustrating for everyone involved.”

It’s clear most consumers want to save money on prescriptions, but rather then chase down lower drug options themselves, they would prefer that their physician help them navigate the process. Eighty-eight percent of RazorMetrics survey respondents said they would be more satisfied with their provider if they talked to them about drug prices. Two-thirds reported they would have a more favorable opinion of their provider if they changed the prescription to a lower cost option. Put simply, patients want their physician to lead on getting affordable prescriptions.

Read more here.

About RazorMetrics
RazorMetrics is a healthcare technology company whose SaaS-based platform uses AI and ML to lower drug spend for health plans, self-insured employers, and consumers. RazorMetrics unique, physician-first approach process that is simple, requires no extra clicks in the EHR and no external programs or apps to access. Switches are straightforward, easy to make, and the entire process stays within the normal clinical workflow. The platform is complementary to existing pharmacy initiatives and works with PBMs and other drug cost savings solutions to optimize results. RazorMetrics is fully scalable and customizable to each client’s unique variables and formularies. For more information, visit www.razormetrics.com.

Media Contact:
Casey DeMoss, RazorMetrics
casey@razormetrics.com
504-982-0468

View original content:https://www.prnewswire.com/news-releases/navigating-high-drug-costs-study-finds-consumers-want-their-physician-to-lead-301528691.html

SOURCE Razor Metrics

Staff

Recent Posts

Massimo Group Signs Letter of Intent to Acquire 100% of AI technology company FST in Drive to Accelerate Its AI-Powered Mobility and Health Technology Strategy

GARLAND, Texas, Feb. 3, 2026 /PRNewswire/ -- Massimo Group (NASDAQ: MAMO) ("Massimo" or the "Company"),…

38 minutes ago

Baysient Launches iDose® GEN7.0, Expanding Precision Dosing Platform to 16 Inflammatory Disease Indications

Next-Generation Decision Support Software Introduces Predictive Clinical Tools for Gastroenterology, Rheumatology, Dermatology, and PulmonologyFORT MYERS,…

38 minutes ago

From the Founders of Fitbit: Introducing Luffu, Your Guardian for Family Health & Safety

After making personal health accessible to millions with Fitbit, James Park and Eric Friedman announce…

38 minutes ago

Embla Medical hf: Interim Report Q4 and Full Year 2025

COPENHAGEN, Denmark, Feb. 3, 2026 /PRNewswire/ -- Announcement no. 5/2026 Interim Report Q4 and Full…

39 minutes ago

UAE Partners with Colossal Biosciences to Protect Biodiversity and Champion the Future of Life on Earth

The collaboration positions the UAE as a global leader in conservation, driving pioneering initiatives in…

39 minutes ago

Case Reports in Regrowth Announces Publication of Muhammad Qasim Observational Case Report and Invites Medical Review

New York, New York--(Newsfile Corp. - February 3, 2026) - Case Reports in Regrowth today…

1 hour ago